Asthma, atopic dermatitis (eczema) and hay fever are IgE-related diseases that are increasing in prevalence and are a major source of disability. Systematic knowledge of IgE production is limited, beyond the regulation of IgE creation in B-cells by Interleukin-4 (IL4) released from T~H~2 cells and eosinophils^[@R7]^. Genome-wide association studies show polymorphisms in *STAT6, FCERIA, IL4/RAD50* and the MHC to be associated with high IgE concentrations^[@R3]-[@R6]^, but these SNPs combined account for only 1-2% of the variation in serum IgE^[@R4]^.

CpG methylation is associated with gene silencing and the patterning of gene expression that determines cellular types and functions^[@R8]^, and islands of CpG (CGI) sequences are positioned near the promoters of 40% of human genes^[@R9]^. *IL4* expression has been related to upstream epigenetic variation in DNA methylation in T-cells^[@R10]^, encouraging us to search genome-wide for other CGI associated with IgE serum concentrations.

We used Illumina HumanMethylation27 arrays to target individual CpG sites (loci) within proximal promoter regions of 14,475 genes. The panel is enriched for genomic regions regulating expression, but does not cover all functionally important CpG sites. We excluded from downstream analyses any loci with SNPs overlapping the Illumina probe sequence, and established that direct bisulphite pyrosequencing correlates robustly with the array in our hands ([Extended Data Figure 1](#F4){ref-type="fig"}) and elsewhere^[@R11]^.

We investigated nuclear families from the MRCA panel in which we have previously carried out genome-wide SNP association studies for IgE levels and asthma^[@R12]^. The panel contained 355 subjects (183 male) with a mean age in children of 12.2 years (ranging from 2 to 39) and adults of 42 years (27 to 61) ([Table 1](#T1){ref-type="table"}). 113 children had doctor-diagnosed asthma (DDAST). We sought for replication in 149 Caucasian subjects selected equally from the top and bottom deciles of IgE distribution in 1,614 unselected volunteers for the PAPA study (Poplogaeth Asthma Prifysgol Abertawe: students and staff from Swansea University)^[@R13]^; and in 160 subjects in an asthmatic family panel from the Saguenay--Lac-Saint-Jean region (SLSJ) of Quebec^[@R14]^ with a mean age in children of 16 years (ranging from 5 to 50; 40 DDAST) and adults of 44 years (31 to 79)([Table 1](#T1){ref-type="table"}).

We fitted models with Ln(IgE) as dependent variable and methylation status for each Illumina probe as a predictor with age, sex, parental status, interactions and batch identifiers as covariates. We identified 34 loci with a false discovery rate (FDR)\<0.01 ([Figure 1](#F1){ref-type="fig"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}) in 32 different CGIs in the MRCA panel. Following replication in PAPA and SLSJ panels a meta-analysis combining the results identified 36 loci with FDR \< 10^−4^ and 62 loci with an FDR\<0.005 ([Table 2](#T2){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). All loci showed associations with the same anti-correlated direction in the three datasets ([Table 2](#T2){ref-type="table"}). A RAST index, quantifying IgE against common allergens^[@R15]^, showed similar but non-independent associations, suggesting common regulation of total and specific IgE. Testing of models with asthma as the dependent variable showed only *LPCAT2* and *ZNF22* to be associated with asthma independently of IgE levels (*P*=7.7×10^−5^ and *P*=1.8×10^−4^).

The variable methylation site upstream of *IL4* has a well-studied effect on IL4 production^[@R16],[@R17]^ and IgE regulation, with methylation anticorrelated with expression in the same direction as in our study. We looked for SNP associations at this locus by imputation with the 1000G phase 1 SNPs and indels in all three panels, analysing the 20,746 variants within 1Mb upstream or downstream of the IL4 5′UTR. We found no significant SNP associations with IgE after accounting for multiple testing.

We carried out Mendelian randomization to test for a causal effect of IL4 methylation on IgE^[@R18]^, choosing the SNP showing strongest association to methylation at the IL4 CpG probe (cg26787239) as the instrumental variable. The First Stage F-test statistics for the MRCA and SLSJ panels (F=16.4 and 26.2) indicated effects strong enough to ensure the validity of the method. In the MRCA panel, association between the instrument SNP (*rs12311504*) and IgE before adjusting for IL4 methylation was P=0.03 and P=0.53 after adjustment, indicating that methylation mediated most of the SNP effect. The meta-analysis *P* for a causal effect was 6.8×10^−4^, suggesting that the locus represents a functionally validated epigenetic association with a complex phenotype.

Several loci were annotated to genes that encode proteins characteristic of eosinophils ([Table 2](#T2){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). *IL5RA* encodes a receptor that selectively stimulates eosinophil production and activation^[@R19]^; *CCR3* encodes the eosinophil eotaxin receptor; *IL1RL1* encodes the receptor for the eosinophil-activating cytokine IL33; *PGR2* encodes eosinophil granule major basic protein (*PRG2*); *PGR3* is a *PGR2* homologue; and *GATA1* is an eosinophil transcription factor. We therefore tested whether methylation at our associated loci marked activation in eosinophils purified from peripheral blood, studying 8 asthmatics with high serum IgE levels (\>110 IU/L), 8 asthmatics with low serum IgE (\<110 IU/L) levels and 8 controls (mean age all subjects 31 years (range 6-56), 8 females and 2 current smokers). Asthmatics in both groups were on a maintenance regime of inhaled beta agonists, augmented with inhaled glucocorticoids during exacerbations.

We observed the lowest levels of methylation in the subjects with asthma and high IgE and that methylation in asthmatics with low IgE was intermediate to controls ([Figure 2](#F2){ref-type="fig"}) (*P* \<0.05; [Supplementary Table 1](#SD1){ref-type="supplementary-material"}), supporting our initial results. Partitioning the data into high or low IgE groups gave similar conclusions. The range of variation for the principal loci was narrower in asthmatics with high IgE ([Figure 2](#F2){ref-type="fig"}) than in the other two groups, suggesting the enrichment of a distinctive eosinophil subset in atopic asthma. This is consistent with the recognised mixture of eosinophil populations in human blood and eosinophil activation in atopic disease^[@R20]^. Comparison of methylation levels in the MRCA panel for our IgE-associated loci (*P*\<0.001) with an independent study of eosinophils isolated from normal subjects^[@R21]^ confirmed correlations with methylation status (R=0.64).

Lineage commitment to particular cell types is accompanied by specific methylation changes^[@R8]^, and it has been suggested that DNA from mixtures of cells (such as PBL) will not support EWAS of complex diseases^[@R21]^. We extracted DNA from unfractionated populations of PBL, so that our methylation patterns reflect the numbers and the activity of different cells in each specimen. We further explored whether our associations to IgE reflected carriage in particular cell types by fitting regression models that included differential white cell counts. We identified partial associations with eosinophil numbers for all IgE associated loci ([Supplementary Table 2](#SD2){ref-type="supplementary-material"} and [Figure 3](#F3){ref-type="fig"}), consistent with independent effects on IgE from the numbers of eosinophils and the activity of the loci within eosinophils.

It is well recognised that the regulation of IgE production against particular antigens may reside in T-cells and B-cells as well as in eosinophils^[@R22]^. Our regression models however found that the top IgE associations were not accounted for by concomitant correlation with lymphocyte counts ([Supplementary Table 2](#SD2){ref-type="supplementary-material"}). We further examined the distribution of our IgE-associated CpG loci in leukocyte subsets isolated in our Centre and in subsets from published data^[@R21]^. The results showed robustly in both datasets that low levels of methylation at the IgE associated loci were confined to eosinophils ([Extended Data Figure 2](#F5){ref-type="fig"}).

Surrogate CpG markers that identify lymphocyte subsets can be used as an alternative to white cell counts in association models^[@R23]^. We also applied these methods to our data ([Extended Data Table 1](#T3){ref-type="table"}). This analysis provided further evidence that T-cell subsets do not have strong effects on these loci.

The variance (Standard Deviation) in our IgE-associated CpG loci was on average 4.4 fold larger in isolated eosinophils than in PBL from the MRCA dataset, indicating an attenuation of effect size in PBL that would mask associations rather magnify them. The power to detect cell-specific associations from PBL depends on the proportion of each cell type, the effect size in specific cells, and the sample size. We estimated that we had 90% power to detect loci accounting for 10% of variance in IgE in the MRCA panel and \>99% power in the combined panels ([Extended Data Figure 3](#F6){ref-type="fig"}). Although our ability to detect associations was enhanced by eosinophil counts that were above the normal range for many of our subjects ([Table 1](#T1){ref-type="table"}), the power estimates and the large observed effect size encourage EWAS of other diseases in which PBLs may be important.

We investigated the variance attributable to different loci in the MRCA panel through a stepwise regression that included all significant CGI associations together with differential white cell counts, age, sex and parental status. Using a cut-off of corrected *P*\<0.1 for inclusion, we found *SLC25A33, LPCAT2* and *L2HGDH* to predict the serum IgE concentration independently of each other and of eosinophil counts.

In the MRCA panel the top 3 CpGs independently explained 13.5% IgE variation and counts 8.8%, and in the SLSJ panel the top 3 CpGs explained 8.3% IgE variation and counts 15.5%. (We were not able to estimate variances meaningfully in the PAPA dataset, because the samples were selected by extreme IgE values). The regression models therefore matched the results from isolated eosinophils, with the conclusion the methylation status of eosinophils and their numbers were both related to IgE levels.

Methylation levels were highly correlated between loci and similar estimations of variance were obtained with forced entry of other significantly associated markers, so the results do not imply that *SLC25A33, LPCAT2* and *L2HGDH* are the most important loci. DNA methylation is not meiotically heritable and the variance in IgE attributable to these loci does not impact on the problem of missing heritability.

Overall, the most significant association was to *cg01998785*, within a CGI adjacent to *LPCAT2 (*also known as *AYTL1*). *LPCAT2* encodes lyso-platelet-activating factor (PAF) acetyltransferase, which is essential to induced formation of PAF, a potent pro-inflammatory lipid mediator^[@R24]^. It is of interest that hypoactive variants of plasmatic PAF-acetylhydrolase are associated with atopy and asthma^[@R25]^. Other significant associations annotated to genes involved in phospholipid metabolism included lysoplasmalogenase (*TMEM86B*), *CEL* and *CLC*.

*GATA1* is a known eosinophil transcription factor and subsequent investigations will determine if the other associated transcription factors *ZNF22, RB1* and *KLF* regulate eosinophil activation. Other associations may encode proteins released from eosinophil granules, including *PRG2, PRG3, SERPINC1* (antithrombin), *TFF1* (which may protect the mucosa), *CEL* (carboxyl ester lipase), and the polyvalent serine protease inhibitor *SPINK4*. Genes encoding mitochondrial proteins (*L2HGDH* and *SLC25A3*) are consistent with mitochondrial suppression of apoptosis in activated eosinophils^[@R26]^.

Although the relationship between methylation and gene expression at these loci requires further investigation in isolated cells, our results support the recognition that eosinophils are an important source of cytokines and other pro-inflammatory molecules at the site of allergic inflammation^[@R7]^. Eosinophils are required locally for the maintenance of bone-marrow plasma cells^[@R27]^, allowing direct regulation of IgE production in specialised environments. Clinically, the presence of eosinophilia in the peripheral blood or airways identifies a subgroup of refractory asthmatic individuals in whom therapies directed at eosinophils may be effective^[@R28]^. The measurement of methylation at these loci may identify patients responsive to therapies directed at eosinophils or individual gene products.

Cigarette smoking may increase serum IgE, and we found anti-correlated associations to current cigarette smoking with *F2RL3* (*P*=8.6×10^−17^) and *GPR15* (*P*=4.6×10^−9^). The SLSJ dataset confirmed these associations (*P*=2.5×10^−6^ and *P*=6.6×10^−7^), in keeping with previous studies^[@R29],[@R30]^. Adjusting for smoking had minimal impact on the top hits for IgE and neither locus affected IgE in our subjects. *F2RL3* and *GPR15* may represent therapeutic targets to counter tobacco smoke and their methylation status may prospectively predict consequences of smoking.

Our EWAS has discovered reproducible CGI associations accounting for a variation in the total serum IgE that is 10 fold higher than that derived from large SNP GWAS^[@R4]^. In contrast to SNP studies, association to methylation levels captures responses to environmental factors and the loci should not be assumed to cause disease. Nevertheless, our findings suggest the presence of novel therapeutically tractable pathways underlying IgE production.

Online Methods {#S1}
==============

Phenotyping {#S2}
-----------

Ethical approval for the study was obtained from the NHS Multicentre Research Ethics Committee for the MRCA subjects; from the Swansea Joint Scientific Research Committee and Swansea Research Ethics Committee for the Swansea (PAPA) subjects; and from le Centre de Santé et des Services Sociaux de Chicoutimi for the SLSJ families. Written informed consent was obtained from all subjects or in the case of children, from their parents. Asthma was doctor defined. Following a standard respiratory questionnaire, all subjects submitted to venipuncture. Differential white cell counts were measured by automated counter. Total serum IgE and specific serum IgE to whole HDM (*Dermatophagoides pteronyssinus*) and Timothy grass pollen (*Phleum pratense)* were measured using the Immunocap FEIA (Pharmacia AB, Uppsala, Sweden). The levels of specific IgE were converted to RAST units according to Pharmacia recommendations. A combined RAST index was calculated for each individual as the sum of the RAST scores to HDM and Timothy grass^[@R15]^.

Detection of Methylation status {#S3}
-------------------------------

DNA was extracted after red cell lysis and centrifugation to recover leukocyte nuclear pellets. DNA samples were bisulfite converted using the Zymo EZ DNA Methylation kit (Zymo Research, Orange, CA, USA) with an input of 1000ng. The assay was carried out as per the Illumina Infinium Methylation instructions, using the HumanMethylation27 BeadChips (Illumina Inc, San Diego, CA, USA). These interrogate 27,578 of CpG sites for the extent of DNA methylation. Data were visualized using the BeadStudio software, and samples that failed quality control were repeated. Raw methylation data was exported from the GenomeStudio software. For the Illumina HumanMethylation27 BeadChip data, quantile normalization of intensity was applied to all methylated and unmethylated probes for all samples together. The methylation β values were recalculated as the ratio of methylated probe signal/(total signal + 100). The Touleimat and Tost^[@R31]^ analysis pipeline was used for the HumanMethylation450 BeadChip. Individual data points with detection *P*\>0.01 or number of beads \<3 were treated as missing data, as were samples with more than 20% missing probes. The lumi package^[@R32]^ was used for background and colour bias correction. BeadChip ID and position on chip were included as categorical covariates to account for potential batch effects. Quantile normalization across samples was applied to probes within each functional category (CpG island, shelf, shore, etc.) separately to correct the shift of methylation beta value between Infinium I and Infinium II probes on the HumanMethylation450 BeadChip. Probe overlaps with any frequent SNP (MAF \>5% in 1000 Genomes Project phase 1 EUR population) in the probe sequence or in position +1 or +2 of the query site (depending on Infinium I or Infinium II status) were removed. The use of meta-analysis to combine 27K and 450K data together with this implementation of the Tost pipeline ensured our analysis was not confounded by probe differences.

Isolation of human eosinophils {#S100}
------------------------------

Isolation of human eosinophils was as described^[@R33]^. Briefly, platelet-rich plasma was removed from 200ml using centrifugation, followed by Dextran-mediated sedimentation to remove erythrocytes and removal of mononuclear cells using a lymphocyte separation medium. Hypotonic lysis with sterile water removed remaining erythrocytes and other granulocytes were removed using negative selection with anti-CD16 MicroBeads. DNA was extracted using the QIAamp® DNA Blood Mini Kit. Methylation was assessed using Illumina 450K arrays, with analysis restricted to significantly associated probes from the meta analysis.

Statistical analyses {#S4}
--------------------

In order to investigate the association with the total serum IgE concentration we tested for association with log-normalized IgE (Ln(IgE)) as response with methylation (β) at each locus as predictor whilst including Sex, Age, Parent indicator, Age\*Sex and Age\*Parent interactions in the model, together with batch indicators captured by Illumina chip ID and position of chip (such as operators, sample wells, plates, runs, and reagents). We applied inverse normal transformation to methylation measures to remove the effect of outliers. We used the R function lme() in the nlme package to implement a linear mixed model, assuming a compound symmetry variance-covariance structure to account for correlation of phenotypes among family members. The R code for the discovery stage of association in the MRCA panel was:

index=!is.na(methylation)

fam=familyID\[index\]

par=parent\[index\]

methylation = methylation \[index\]

methylation =qnorm(rank(methylation)/(length(methylation)+1),mean=0,sd=1)

lnige=LNIGE\[index\]

age=AGE\[index\]

sex=SEX\[index\]

lm2=lme(lnige\~sex+age+methylation+par+sex\*age+age\*par,random=\~1\|fam)

The residual methylation value after removal of effects of chip ID and position for the genome-wide significant loci in the MRCA, PAPA and SLSJ panels is provided in [Supplementary Tables 3](#SD3){ref-type="supplementary-material"}-[5](#SD5){ref-type="supplementary-material"}, together with phenotypic and covariate parameters. We calculated false discovery rates (FDR) and applied Bonferroni corrections to adjust for multiple comparisons to 27,578 probes. The same analyses were carried out in the PAPA and SLSJ subjects before meta-analysis of the three datasets. We use a weighted z-score method for meta-analysis based on pvalue and effect direction from individual studies with weights proportion to the square root of sample size of individual study^[@R34]^. SNPs and indels from the 1000 Genomes Project phase 1 release (2012-03-14 haplotypes) were imputed using MINIMAC^[@R35]^. SNPs or indels with imputation quality score R^2^\<0.3 were removed from downstream analysis. We carried out Mendelian randomization to assess the causal effect of IL4 methylation on IgE level through a 2 stage least square instrumental variable regression^[@R36]^ implemented in the ivreg2.r program (<http://diffuseprior.wordpress.com/2012/05/03/an-ivreg2-function-for-r/>). We tested association trends in isolated eosinophils by exact regression (Cytel Studio 9) with asthma/high IgE coded as 2, asthma/low IgE coded as 1, and controls as 0. Covariates for age, sex, and batch were included in the model and to test the hypothesis that low levels of methylation were associated with high IgE, *P* values were one-sided. Differences in methylation between peripheral blood leukocyte subsets were assessed with Kruskal-Wallis tests, using two-sided *P* values.

Extended Data {#S5}
=============

![Concordance in methylation status at IgE-associated loci when comparing whole-genome bisulphite sequencing (WGBS) with the Illumina platform\
These results were produced by us (EG and TMP) at the Genome Quebec Innovation Centre. The figures show a comparison between IgE-associated CpG probes using Illumina 450K (x-axis) and WGBS (y-axis) platforms for two samples (left and right panels) with 20 fold sequence coverage. The results show a high R^2^ between platforms (0.76 and 0.73). The median of the correlation coefficients for our IgE associated loci across 30 different samples (using WGBS at various depths) was R^2^=0.76. This to be compared with the global assessment of all overlapping 450K sites which is R^2^=0.81.](emss-61290-f0001){#F4}

![Distribution of methylation status at IgE-associated loci in isolated leukocyte subsets\
The figure shows the distribution of methylation in peripheral blood leukocyte subsets at the most strongly IgE-associated loci. CpG methylation was measured by the Illumina Infinium 450K platform. Boxplots show means and interquartile ranges. **a, c, e, g, i, k)** Results from publically available data derived from 6 healthy controls (Reinius *et al* ^[@R21]^). Lower levels of methylation with wider variation is observed in eosinophils when compared to whole blood (WB) and subsets comprising CD14+ Monocytes (CD14+M); CD19+ B cells (CD19+B); CD4+ T-cells (CD4+T); CD56+ natural killer cells (CD56+NK); CD8+ T cells (CD8+T); granulocytes (Gran); Neutrophils (Neu) and PBMC. **b, d, f, h, j, l)** Results from cells isolated and analyzed by us at the Genome Quebec Innovation Centre (GQIC). Eosinophils (Eos) (from 24 subjects in the SLSJ panel) also show lower levels of methylation with wider variation compared to whole blood (WB, 22 SLSJ subjects), and to subsets including B-cells (BC, 9 control subjects), Monocytes (Mono, 76 control subjects), and T-cells (TC, 74 control subjects).](emss-61290-f0002){#F5}

![Power estimations to detect eosinophil-specific effects in DNA from peripheral blood lymphocytes\
The figure shows that our original MRCA dataset (green line) and our combined dataset (blue line) are well powered to detect signals of the magnitude observed in our three groups of subjects. The red line shows the power of sample size of 6 described in Reinius *et al.*^[@R21]^ to detect differences in CpG methylation in unfractionated PBL. The mean variance (as standard deviation, SD) for the IgE-associated loci was 0.036 in PBLs from our primary MRCA panel and 0.023 in the whole blood normal samples from Reinius *et al.*^[@R21]^, demonstrating that our results were consistent with the previous experiment.](emss-61290-f0003){#F6}

###### Comparison of surrogate variable analyses with direct white cell counts in association models

The table shows the I values from regression models in the MRCA panel that predict lnIgE at each locus a) before adjusting cell counts; b) after adjusting cell counts using Houseman surrogate variables; c) after adjusting for cell subsets counted in our data. pMethyl measures strength of association to IgE. CD8, CD4 and NK are Tcell subsets, GRAN= granulocytes, EOS=eosinophils, NEU=neutrophil, LYM=lymphocytes, MON=monocytes, BAS=basophils. All models are adjusted for sex, age, methylation, parent/child status, sex\*age interaction, and age\*parent interaction.

  a\) Before adjusting cell counts   b\) Adjusting for Houseman cell proportions   c\) Adjusting for white cell counts                                                                                                                                                                       
  ---------------------------------- --------------------------------------------- ------------------------------------- ------------ ---------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ---------- ---------- ---------- ---------- ----------
  1                                  9521654                                       SLC25A33                              cg18783781   4.96E-14   5.58E-13    0.3625663   0.6489145   0.0830001   0.0735391   0.7715233   0.2564499   6.14 E-06   0.00065    0.866661   0.678896   0.561016   0.551752
  16                                 54100210                                      LPCAT2                                cg01998785   1.24E-13   3.81E-13    0.1560292   0.3633042   0.034881    0.0300831   0.7239839   0.1881862   2.36E-06    0.0003     0.294806   0.300248   0.445243   0.785135
  14                                 49849865                                      L2HGDH                                cg15996947   7.39E-13   3.81E-11    0.3709841   0.6823007   0.125117    0.1583239   0.9387673   0.3768824   3.21E-05    0.000295   0.38062    0.519495   0.662394   0.890493
  10                                 44815441                                      ZNF22                                 cg01614759   4.42E-12   9.09E-11    0.3526504   0.6420391   0.1382946   0.0810812   0.654088    0.3845248   7.61E-05    0.000216   0.305013   0.42021    0.601202   0.937252
  3                                  3127530                                       IL5RA                                 cg10159529   5.06E-12   1.70E-10    0.8786628   0.9388517   0.2941882   0.2701973   0.9752202   0.5129874   0.000104    6.81E-05   0.877227   0.802458   0.551635   0.756105
  1                                  172153108                                     SERPINC1                              cg01770400   6.59E-12   1.54E-11    0.1182883   0.3063038   0.0323251   0.0368702   0.574556    0.1896      6.36E-06    0.000109   0.236406   0.186757   0.667289   0.90807
  21                                 42659768                                      TFF1                                  cg02643667   7.87E-12   6.81E-11    0.234861    0.4646176   0.0330799   0.0706689   0.797703    0.1753888   9.07E-06    7.18E-06   0.384611   0.725574   0.672431   0.976409
  5                                  132036424                                     IL4                                   cg26787239   1.59E-11   2.13E-10    0.5058003   0.9922092   0.1723318   0.1996409   0.7364825   0.6544331   1.25E-05    1.66E-05   0.269226   0.259295   0.614387   0.77939
  2                                  110014086                                     LIMS3                                 cg18879041   4.06E-11   2.57E-09    0.3708111   0.7030526   0.1613161   0.2166898   0.9745824   0.474026    0.000865    0.000256   0.280498   0.382954   0.500203   0.963467
  13                                 47774920                                      RB1                                   cg13221796   5.66E-10   9.26E-11    0.1278218   0.3641314   0.0353766   0.0458363   0.7786051   0.2987393   2.84E-06    1.83E-05   0.029037   0.081617   0.516731   0.982861
  19                                 60432000                                      TMEM86B                               cg26457013   1.02E-09   4.08E-09    0.3305229   0.5920938   0.036091    0.0792481   0.9078355   0.2711535   0.000691    1.35E-05   0.363948   0.317448   0.558421   0.740734
  9                                  100745613                                     COL15A1                               cg20503329   1.19E-09   3.14E-08    0.4772819   0.7388277   0.1359031   0.1343368   0.9433195   0.4284566   0.001341    1.17E-05   0.443838   0.49736    0.401174   0.959364
  1                                  31166502                                      SDC3                                  cg07689731   2.33E-09   4.79E-09    0.5074834   0.7985815   0.0774502   0.0726484   0.7924958   0.4108301   0.002906    1.48E-05   0.415182   0.483806   0.437372   0.932638
  21                                 45317773                                      ADARB1                                cg09676390   1.21E-08   1.32E-07    0.43369     0.6702876   0.0791369   0.1103603   0.9234331   0.3292778   0.000472    3.48E-07   0.432091   0.530921   0.462608   0.820656
  9                                  134926722                                     CEL                                   cg03693099   1.84E-08   1.01E-07    0.2926779   0.512945    0.0818301   0.1071869   0.9754856   0.3848947   0.000383    9.27E-06   0.099207   0.18224    0.575481   0.93957
  19                                 12859426                                      KLF1                                  cg26136776   3.34E-08   5.42E-07    0.2328607   0.4764967   0.0498737   0.087521    0.7661611   0.2312155   0.008494    4.25E-06   0.308908   0.378613   0.526765   0.764392
  X                                  48529968                                      GATA1                                 cg00536175   7.85E-08   5.70E-07    0.6056632   0.9159691   0.163687    0.1102612   0.8082841   0.5675393   0.002444    1.31E-06   0.230592   0.333849   0.423511   0.745501
  12                                 10222881                                      TMEM52B                               cg25494227   1.29E-07   2.79E-07    0.4810187   0.6746518   0.0457622   0.0735827   0.9017706   0.3386288   8.31E-05    2.05E-08   0.349366   0.362883   0.456694   0.75634
  9                                  33229641                                      SPINK4                                cg00079056   1.54E-07   1.23E-06    0.3893041   0.6595419   0.067607    0.090288    0.950103    0.3262354   0.015058    9.70E-07   0.327361   0.481372   0.49343    0.779557
  12                                 15017287                                      PDE6H                                 cg09447105   2.16E-07   1.80E-06    0.6038815   0.9752817   0.1325361   0.2619219   0.6725442   0.6818338   0.002327    6.73E-07   0.185319   0.308805   0.650588   0.72691
  16                                 4778723                                       FLJ25410                              cg05215575   3.11E-07   7.40E-08    0.6354446   0.6693211   0.0382164   0.0635217   0.8705757   0.2084314   0.011151    9.08E-08   0.699883   0.891282   0.341595   0.856081
  7                                  142369547                                     KEL                                   cg17784922   4.24E-07   9.07E-07    0.6926023   0.9854571   0.0699431   0.1577229   0.8028496   0.5052827   0.001391    3.21E-08   0.505128   0.698535   0.367309   0.99912
  7                                  29199993                                      CHN2                                  cg21472642   6.51E-07   7.39E-07    0.5225896   0.8312874   0.0708089   0.0764603   0.9022296   0.4725488   8.45E-06    3.38E-09   0.104506   0.231601   0.595919   0.815002
  2                                  191009029                                     FLJ20160                              cg15998761   9.33E-07   9.09E-06    0.4236314   0.824669    0.1393183   0.1145142   0.8527446   0.4643437   0.043732    5.71E-07   0.331558   0.449501   0.418024   0.785659
  6                                  25862169                                      SLC17A4                               cg21627181   1.14E-06   1.42E-06    0.7663137   0.9149808   0.0591244   0.1414494   0.9511792   0.3972344   0.025202    5.30E-08   0.609342   0.865393   0.467443   0.746032
  14                                 49849874                                      L2HGDH                                cg20189937   1.32E-06   1.16E-05    0.503935    0.9204654   0.0921306   0.1950088   0.8817908   0.5174749   0.007269    1.26E-07   0.297519   0.525586   0.480584   0.958405
  17                                 39822093                                      ITGA2B                                cg17749520   1.37E-06   9.24E-06    0.3677214   0.6752543   0.046072    0.1157269   0.8717913   0.3274826   0.009625    3.11E-07   0.286277   0.406727   0.666483   0.903995
  17                                 39701014                                      SLC4A1                                cg03580247   1.51E-06   1.76E-05    0.4966594   0.7030166   0.1566437   0.1201467   0.7706213   0.4809553   9.19E-05    7.97E-09   0.262889   0.282218   0.522557   0.944193
  20                                 41789039                                      FAM112A                               cg11398517   2.42E-06   2.11E-05    0.431888    0.7316467   0.0506171   0.209415    0.8337169   0.4256838   0.006763    1.86E-07   0.220078   0.444385   0.592602   0.918166
  11                                 56904791                                      PRG3                                  cg24459209   3.33E-06   1.29E-05    0.5460024   0.9366639   0.0692143   0.1545826   0.8947187   0.4338765   0.094895    2.69E-07   0.444762   0.62114    0.500854   0.993962
  12                                 7792928                                       CLEC4C                                cg22194129   5.46E-06   0.0001208   0.4977092   0.8378959   0.0710935   0.6019842   0.8886589   0.4447889   0.023532    2.38E-08   0.408481   0.759002   0.521453   0.818552
  14                                 95011802                                      C14orf49                              cg16522484   8.04E-06   0.0001668   0.4308412   0.7282314   0.1486239   0.1112817   0.9482318   0.4206034   0.034072    1.01E-07   0.285777   0.449644   0.49125    0.837548
  X                                  48529554                                      GATA1                                 cg22543648   9.51E-06   7.12E-05    0.682124    0.9511741   0.1312401   0.1917101   0.6997158   0.4748147   0.02664     2.00E-08   0.585973   0.689124   0.425854   0.888172
  2                                  11727816                                      NTSR2                                 cg25657834   1.02E-05   2.04E-05    0.9354409   0.6331433   0.1373482   0.3261244   0.4920064   0.8015518   5.67E-05    4.84E-10   0.191813   0.526463   0.689339   0.954103
  19                                 48912054                                      IRGC                                  cg26251865   1.76E-05   9.19E-06    0.714389    0.9562959   0.0555475   0.1095196   0.6922884   0.4367507   0.011533    1.35E-08   0.495745   0.567965   0.468957   0.977824
  19                                 44919789                                      CLC                                   cg18254848   1.77E-05   2.33E-05    0.7122613   0.874791    0.0834931   0.1954486   0.6341788   0.5277066   0.161753    4.77E-08   0.462599   0.67872    0.424877   0.937408
  6                                  10635801                                      GCNT2                                 cg26385286   1.78E-05   3.88E-05    0.5747779   0.9758809   0.0654066   0.2046998   0.6574459   0.5308099   0.070861    4.31E-08   0.339931   0.593173   0.451377   0.902264
  3                                  150064527                                     CPA3                                  cg13424229   1.89E-05   2.29E-06    0.4329161   0.6962458   0.1048729   0.0674688   0.7084296   0.6214492   0.001236    4.96E-07   0.054043   0.094343   0.451245   0.955257
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###### Manhattan plot of the results of the genome-wide methylation association study

The results of genome-wide association testing to CGI are shown for 27,000 loci in 355 subjects from the MRCA panel of families. **a**) The QQ plot showing observed vs. expected −log~10~*P* values for association at all loci. **b**) Manhattan plot showing chromosomal locations of −log~10~*P* values for association at each locus. The red line illustrates the threshold for a False Discovery Rate (FDR) \<0.01.
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![Boxplots of methylation at selected CpG loci in isolated eosinophils from subjects with and without asthma and high total serum IgE concentrations (\>110 IU/l)\
Subjects were derived from the SLSJ population. Methylation (β) is shown on a scale of 0-1 for 8 subjects in each group. Boxplots show means and interquartile ranges. The intensity of the data point colour is proportion to total serum IgE. All loci exhibited reduced variability and levels of methylation in the subjects with asthma and high IgE (*P*\<0.05).](emss-61290-f0006){#F2}

![Association of selected CpG loci to total serum IgE concentrations in the MRCA panel, partitioned by eosinophil counts\
Methylation values for 355 individuals normalised around a mean of 0 on the abscissa (x) with ln(IgE) levels on the ordinate. Blue dots indicate subjects with eosinophil counts greater than the median for the MRCA panel.](emss-61290-f0007){#F3}

###### Subject characteristics

                                                                              MRCA (discovery)   PAPA (1st replication)   SLSJ (2nd replication)
  --------------------------------------------------------------------------- ------------------ ------------------------ ------------------------
  **Number**                                                                  355                149                      160
  **Age (Mean, range)**                                                       28, 2-61           21, 18-30                29, 5-79
  **N (%) Female**                                                            172 (48.5%)        72 (48.3%)               80 (50.0%)
  **N (%) Asthmatic**                                                         175 (49.3%)        34 (22.8%)               69 (43.1%)
  **N (%) Smokers**                                                           45 (12.7%)         33 (22.1%)               28 (17.5%)
  **Eosinophil count (mean ± SE) per mcl** [\*](#TFN1){ref-type="table-fn"}   406±383            246±214                  242±205
  **Geometric Mean Serum IgE (Range) IU/L** [¶](#TFN2){ref-type="table-fn"}   320, 1-4999        663, 0-18800             412, 2-7653

Normal range \<350 cells per mcl;

Normal range \<100 IU/L

###### Meta-analysis of association of total serum IgE concentration in three subject panels

  Probe              Symbol       Function                                                       *P* MRCA   *P* SLSJ   *P* PAPA   *P* Meta
  ------------------ ------------ -------------------------------------------------------------- ---------- ---------- ---------- ----------
  ***cg01998785***   *LPCAT2*     Lysophospholipid metabolism                                    1.2E-13    8.0E-03    9.6E-06    1.2E-18
  ***cg10159529***   *IL5RA*      Cytokine signalling                                            5.1E-12    2.1E-04    7.2E-05    2.2E-18
  ***cg01614759***   *ZNF22*      Transcription Factor                                           4.4E-12    3.4E-03    2.8E-06    2.8E-18
  ***cg15996947***   *L2HGDH*     Mitochondrial oxidoreductase                                   7.4E-13    1.0E-02    3.7E-05    2.8E-17
  ***cg26787239***   *IL4*        Cytokine signalling                                            1.6E-11    1.3E-03    4.8E-04    3.2E-16
  ***cg18783781***   *SLC25A33*   Mitochondrial transport: dendritic cell endocytosis            5.0E-14    3.4E-02    6.2E-03    4.4E-15
  ***cg13221796***   *RB1*        Transcription Factor                                           5.7E-10    6.0E-02    4.9E-06    2.5E-14
  ***cg01770400***   *SERPINC1*   Anti-thrombin                                                  6.6E-12    7.0E-03    1.3E-02    5.3E-14
  ***cg02643667***   *TFF1*       Mucus stabilising secreted protein                             7.9E-12    1.3E-01    2.6E-03    7.6E-13
  ***cg21627181***   *SLC17A4*    Sodium/phosphate cotransporter                                 1.1E-06    1.4E-04    3.8E-04    1.1E-12
  ***cg20189937***   *L2HGDH*     Mitochondrial oxidoreductase                                   1.3E-06    2.4E-03    3.2E-05    2.6E-12
  ***cg26457013***   *TMEM86B*    Lysoplasmalogenase: phospholipid metabolism                    1.0E-09    9.5E-02    9.0E-04    7.1E-12
  ***cg20503329***   *COL15A1*    Cell shape, motlity, adhesion                                  1.2E-09    3.0E-01    8.8E-05    9.5E-12
  ***cg03693099***   *CEL*        Secreted carboxyl ester lipase                                 1.8E-08    1.1E-01    8.3E-05    1.3E-11
  ***cg00079056***   *SPINK4*     Serine peptidase inhibitor                                     1.5E-07    6.4E-02    3.1E-05    1.8E-11
  ***cg09676390***   *ADARB1*     Pre-mRNA editing of the glutamate receptor                     1.2E-08    7.0E-02    8.0E-04    3.1E-11
  ***cg15998761***   *MFSD6*      MHC receptor homolog                                           9.3E-07    1.3E-02    1.7E-04    4.5E-11
  ***cg25494227***   *TMEM52B*    Transmembrane protein                                          1.3E-07    2.0E-01    1.2E-05    5.1E-11
  ***cg11398517***   *FAM112A*                                                                   2.4E-06    7.4E-03    3.3E-04    1.0E-10
  ***cg06690548***   *SLC7A11*    Cystine/glutamate antiporter: dendritic cell differentiation   2.7E-05    3.3E-04    1.1E-03    1.8E-10
  ***cg17784922***   *KEL*        Metallo-endopeptidase                                          4.2E-07    7.9E-03    4.4E-03    2.1E-10
  ***cg16050349***   *PIK3CB*     Catalytic subunit for PI3Kbeta: activation of neutrophils      4.0E-05    1.7E-03    2.3E-04    3.2E-10
  ***cg25636075***   *TMEM41A*    Transmembrane protein                                          2.5E-04    5.1E-05    7.7E-04    3.9E-10
  ***cg08404225***   *IL5RA*      Cytokine signalling                                            2.3E-04    3.3E-03    8.4E-06    4.1E-10
  ***cg09447105***   *PDE6H*      Inhibitory subunit of cGMP phosphodiesterase                   2.2E-07    1.3E-01    4.0E-04    5.3E-10
  ***cg05215575***   *SEPT12*     Cell shape, motlity, adhesion                                  3.1E-07    2.1E-01    2.7E-04    1.2E-09
  ***cg26136776***   *KLF1*       Erythroid-specific transcription factor                        3.3E-08    4.3E-01    6.6E-04    1.5E-09
  ***cg17749520***   *ITGA2B*     Platelet fibronectin receptor: role in coagulation             1.4E-06    2.5E-02    3.5E-03    1.8E-09
  ***cg24459209***   *PRG3*       Eosinophil major basic protein homolog                         3.3E-06    2.9E-02    1.1E-03    1.8E-09
  ***cg00002426***   *SLMAP*      Sarcolemma associated protein                                  7.9E-05    8.3E-03    1.6E-04    2.4E-09
  ***cg15357945***   *PRG2*       Eosinophil granule major basic protein                         2.2E-03    2.8E-05    5.8E-04    3.1E-09
  ***cg17582777***   *EFNA3*      Receptor protein-tyrosine kinase                               1.1E-04    3.1E-02    8.2E-05    8.6E-09
  ***cg19881895***   *SLC43A3*    Transmembrane protein                                          7.5E-05    2.8E-03    6.7E-03    1.6E-08
  ***cg18254848***   *CLC*        Lysophospholipid metabolism                                    1.8E-05    4.4E-02    4.6E-03    4.5E-08
  ***cg21631409***   *ALDH3B2*    Enzyme or Kinase                                               2.3E-04    1.7E-02    1.2E-03    6.8E-08
  ***cg00536175***   *GATA1*      Eosinophil transcription factor                                7.9E-08    4.0E-01    5.1E-02    1.4E-07

Loci with a false discovery rate for the meta-analysis \<10^−4^ are shown: a full list of significant associations is in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. Markers are identified through their Illumina IDs and the associated gene symbol is derived from the Illumina annotation updated through PubMed. Note that two probes from *IL5RA* and from *L2HGDH* are associated to IgE concentrations.
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